- Home
- TSSI vs PRQR Comparison
TSSI vs PRQR Comparison
Compare TSSI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSSI
- PRQR
- Stock Information
- Founded
- TSSI 2004
- PRQR 2012
- Country
- TSSI United States
- PRQR Netherlands
- Employees
- TSSI N/A
- PRQR N/A
- Industry
- TSSI Professional Services
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- TSSI Consumer Discretionary
- PRQR Health Care
- Exchange
- TSSI Nasdaq
- PRQR Nasdaq
- Market Cap
- TSSI 353.7M
- PRQR 309.5M
- IPO Year
- TSSI N/A
- PRQR 2014
- Fundamental
- Price
- TSSI $7.33
- PRQR $1.61
- Analyst Decision
- TSSI
- PRQR Strong Buy
- Analyst Count
- TSSI 0
- PRQR 6
- Target Price
- TSSI N/A
- PRQR $9.00
- AVG Volume (30 Days)
- TSSI 640.4K
- PRQR 679.6K
- Earning Date
- TSSI 05-15-2025
- PRQR 05-08-2025
- Dividend Yield
- TSSI N/A
- PRQR N/A
- EPS Growth
- TSSI 7042.86
- PRQR N/A
- EPS
- TSSI 0.24
- PRQR N/A
- Revenue
- TSSI $148,144,000.00
- PRQR $21,212,711.00
- Revenue This Year
- TSSI N/A
- PRQR $6.44
- Revenue Next Year
- TSSI N/A
- PRQR N/A
- P/E Ratio
- TSSI $30.67
- PRQR N/A
- Revenue Growth
- TSSI 172.33
- PRQR 85.91
- 52 Week Low
- TSSI $0.88
- PRQR $1.07
- 52 Week High
- TSSI $18.26
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- TSSI N/A
- PRQR 52.98
- Support Level
- TSSI N/A
- PRQR $1.47
- Resistance Level
- TSSI N/A
- PRQR $2.02
- Average True Range (ATR)
- TSSI 0.00
- PRQR 0.16
- MACD
- TSSI 0.00
- PRQR 0.02
- Stochastic Oscillator
- TSSI 0.00
- PRQR 42.55
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: facilities, and systems integration. It generates the majority of its revenue from Systems integration services. It generates revenue from the United States.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.